INNOHEP
LEO
Identification
- Active ingredient (INN)
- TINZAPARINE SODIQUE
- Internal code
- 12 B 097
- Country of Origin
- France
- Pharmaceutical form
- SC Injectable Solution (Pre-filled Syringe)
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/02 sering. prerempl. de 0.25ml avec système de securite d'aiguille
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Prophylactic treatment of venous thromboembolic disease in surgery in adult patients, particularly in orthopaedic, general or carcinogenic surgery Prophylactic treatment of venous thromboembolic disease in adult patients immobilized due to acute medical pathology, including acute heart failure, acute respiratory failure, severe infection, active cancer and rheumatism disease in the development of the system.
Prevention of coagulation of the extracorporal circulation circuit during haemodialysis and hemofiltration in adults.
Associated Conditions
The following conditions are met: a) the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the patient should be treated with a prophylaxis in the prophylaxis in the.
Mechanism of Action
A general chemisty group: a low molecular weight heparin group, a heparin group, an ATC code: B01AB10.
Mechanism of action
Enzymatic depolymerization of standard unfractionated l-heparin.
As standard heparin,tinzaparin sodium exerts its anticoagulant action by potentising inhibition of coagulation factors activated by l-antithrombin III, mainly factor Xa.
Biological activity oftinzaparin sodium is standardized by the laboratory activity of the sodic tinzaparin, a low-level anti-heparin-defecting fraction II, an anthrobetic fraction II, anthrobetic fraction II, anthrobic fraction II, anthrobic fraction II, anthrobic fraction II, anthrobic fraction II, anthrobic fraction II, anthrobic fraction II, anthrobic fraction II, anthrobic fraction II, anthrobic fraction II, anthrobic fraction II, anthrobic fraction II, anthrobic fraction II, anthobic fraction II.
Adverse Effects
The most commonly reported adverse reactions are: 1st and 1st (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal) disorders (abnormal (abnormal) disorders.